Literature DB >> 19307712

Mycobacterium tuberculosis pantothenate kinase: possible changes in location of ligands during enzyme action.

Bhaskar Chetnani1, Satyabrata Das, Parimal Kumar, A Surolia, M Vijayan.   

Abstract

The crystal structures of complexes of Mycobacterium tuberculosis pantothenate kinase with the following ligands have been determined: (i) citrate; (ii) the nonhydrolysable ATP analogue AMPPCP and pantothenate (the initiation complex); (iii) ADP and phosphopantothenate resulting from phosphorylation of pantothenate by ATP in the crystal (the end complex); (iv) ATP and ADP, each with half occupancy, resulting from a quick soak of crystals in ATP (the intermediate complex); (v) CoA; (vi) ADP prepared by soaking and cocrystallization, which turned out to have identical structures, and (vii) ADP and pantothenate. Solution studies on CoA binding and catalytic activity have also been carried out. Unlike in the case of the homologous Escherichia coli enzyme, AMPPCP and ADP occupy different, though overlapping, locations in the respective complexes; the same is true of pantothenate in the initiation complex and phosphopantothenate in the end complex. The binding site of MtPanK is substantially preformed, while that of EcPanK exhibits considerable plasticity. The difference in the behaviour of the E. coli and M. tuberculosis enzymes could be explained in terms of changes in local structure resulting from substitutions. It is unusual for two homologous enzymes to exhibit such striking differences in action. Therefore, the results have to be treated with caution. However, the changes in the locations of ligands exhibited by M. tuberculosis pantothenate kinase are remarkable and novel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19307712     DOI: 10.1107/S0907444909002170

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  8 in total

1.  Structure of uracil-DNA glycosylase from Mycobacterium tuberculosis: insights into interactions with ligands.

Authors:  Prem Singh Kaushal; Ramappa K Talawar; Umesh Varshney; M Vijayan
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-07-27

2.  Cloning, expression, purification, crystallization and preliminary X-ray studies of argininosuccinate lyase (Rv1659) from Mycobacterium tuberculosis.

Authors:  A Paul; A Mishra; A Surolia; M Vijayan
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-11-29

Review 3.  Protein targets for structure-based anti-Mycobacterium tuberculosis drug discovery.

Authors:  Zhiyong Lou; Xiaoxue Zhang
Journal:  Protein Cell       Date:  2010-06-04       Impact factor: 14.870

4.  Structural studies on Mycobacterium tuberculosis RecA: molecular plasticity and interspecies variability.

Authors:  Anu V Chandran; J Rajan Prabu; Astha Nautiyal; K Neelakanteshwar Patil; K Muniyappa; M Vijayan
Journal:  J Biosci       Date:  2015-03       Impact factor: 1.826

5.  Biochemical and structural studies of mutants indicate concerted movement of the dimer interface and ligand-binding region of Mycobacterium tuberculosis pantothenate kinase.

Authors:  A Paul; P Kumar; A Surolia; M Vijayan
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-10-30       Impact factor: 1.056

6.  Structural and biochemical characterization of compounds inhibiting Mycobacterium tuberculosis pantothenate kinase.

Authors:  Christofer Björkelid; Terese Bergfors; Anand Kumar V Raichurkar; Kakoli Mukherjee; Krishnan Malolanarasimhan; Balachandra Bandodkar; T Alwyn Jones
Journal:  J Biol Chem       Date:  2013-05-09       Impact factor: 5.157

Review 7.  Vitamin in the Crosshairs: Targeting Pantothenate and Coenzyme A Biosynthesis for New Antituberculosis Agents.

Authors:  Hailey S Butman; Timothy J Kotzé; Cynthia S Dowd; Erick Strauss
Journal:  Front Cell Infect Microbiol       Date:  2020-12-15       Impact factor: 5.293

8.  Molecular modeling studies and in vitro screening of dihydrorugosaflavonoid and its derivatives against Mycobacterium tuberculosis.

Authors:  Ninad V Puranik; Pratibha Srivastava; Sagar Swami; Amit Choudhari; Dhiman Sarkar
Journal:  RSC Adv       Date:  2018-03-16       Impact factor: 3.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.